Selegiline Transdermal System: In the Treatment of Major Depressive DisorderA Viewpoint by J. Alexander Bodkin

被引:0
|
作者
J. Alexander Bodkin
机构
[1] Harvard Medical School,Consolidated Department of Psychiatry
关键词
D O I
10.2165/00003495-200767020-00007
中图分类号
学科分类号
摘要
引用
收藏
页码:266 / 266
相关论文
共 50 条
  • [1] Selegiline Transdermal System: In the Treatment of Major Depressive DisorderA Viewpoint by Thomas C. Baghai
    Thomas C. Baghai
    Drugs, 2007, 67 (2) : 266 - 267
  • [2] Selegiline transdermal system: In the treatment of major depressive disorder
    Bodkin, J. Alexander
    DRUGS, 2007, 67 (02) : 266 - 266
  • [3] Selegiline Transdermal System In the Treatment of Major Depressive Disorder
    James E. Frampton
    Greg L. Plosker
    Drugs, 2007, 67 : 257 - 265
  • [4] Selegiline transdermal system in major depressive disorder
    Patkar, Ashwin A.
    Portland, Kimberly B.
    Pae, Chi-Un
    NEUROPSYCHIATRY, 2012, 2 (02) : 125 - 134
  • [5] Selegiline transdermal system: a novel treatment option for major depressive disorder
    Nandagopal, Jayasree J.
    DelBello, Melissa P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (10) : 1665 - 1673
  • [6] Selegiline Transdermal System in Major Depressive DisorderProfile Report
    James E. Frampton
    Greg L. Plosker
    CNS Drugs, 2007, 21 : 521 - 524
  • [7] Selegiline transdermal system in the treatment of depressive disorders
    Baghai, Thomas C.
    Eser, Daniela
    Schule, Cornelius
    Born, Christoph
    Rupprecht, Rainer
    FUTURE NEUROLOGY, 2007, 2 (06) : 601 - 611
  • [8] Critical appraisal of selegiline transdermal system for major depressive disorder
    Cristancho, Mario A.
    Thase, Michael E.
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (05) : 659 - 665
  • [9] A critical appraisal of the selegiline transdermal system for major depressive disorder
    Bied, Adam M.
    Kim, Jungjin
    Schwartz, Thomas L.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (06) : 673 - 681